A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge.
about
Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccinationComparative vaccine studies in HLA-A2.1-transgenic mice reveal a clustered organization of epitopes presented in hepatitis C virus natural infection.Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.Detection of natural infection with Mycobacterium intracellulare in healthy wild-caught Chacma baboons (Papio ursinus) by ESAT-6 and CFP-10 IFN-gamma ELISPOT tests following a tuberculosis outbreakSIVsm Tat, Rev, and Nef1: functional characteristics of r-GV internalization on isotypes, cytokines, and intracellular degradation.Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimenRole of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in MacaquesImpairment of Gag-specific CD8(+) T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques.Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeysProtection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectorsPlasmidic versus insertional cloning of heterologous genes in Mycobacterium bovis BCG: impact on in vivo antigen persistence and immune responsesIdentification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicityPrior vaccination increases the epitopic breadth of the cytotoxic T-lymphocyte response that evolves in rhesus monkeys following a simian-human immunodeficiency virus infection.Characterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunizationVaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5)Emergence of virus escape mutants after immunization with epitope vaccine.Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys.Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine.Simian immunodeficiency virus DNA vaccine trial in macaques.The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolateInduction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.Mycobacterium bovis Bacille Calmette-Guérin as a Vaccine Vector for Global Infectious Disease ControlOral immunization with recombinant Mycobacterium bovis BCG simian immunodeficiency virus nef induces local and systemic cytotoxic T-lymphocyte responses in mice.
P2860
Q24646818-07F8573E-5789-4789-914B-41916A5D8C50Q27472916-0A6199FD-DA16-4F71-9981-E1AE7FF8703DQ30387447-E289ADCE-4CEC-4270-A04F-91DDAE95659CQ33318591-93876CA3-0240-497F-A1C2-2552C0B20EA5Q33636080-D093CD84-CCA8-46B6-BB91-0556AA4AC96EQ33649842-82391C51-C653-46E2-9D9E-1BD83F9563C9Q33819493-813F1B03-A495-45A8-8890-041A9863D1D9Q33849823-9A159930-404F-4C2E-A61C-19D2B09750B4Q33850904-39704A6B-87BB-45F7-98D0-BA9BF50AC4B3Q33852720-5BBFF4CB-7585-4ED2-B516-3FE1321F6DB2Q34116296-43602A1E-56ED-4807-B770-91E3672A1BE7Q34186587-F47BC582-477A-4551-AC14-08B4095DF64FQ34340366-9BC5FF0D-1F4C-483F-B203-B36B2EDE10F8Q34342413-9D13E7F8-A536-4555-9438-9A77FA6DEA50Q35848231-076AA9BE-9995-4B27-BD44-D129D839E4D4Q35851158-3789BC81-083F-4883-958B-F2308DE46594Q35854152-E8D95C44-D35E-4377-AEA8-2C712E6C87B6Q35857571-B1F7E9EE-8D9C-4CB0-8033-68C4502BB3EDQ35861970-76322D98-8889-4E67-B91F-D7D4A5CC60A9Q35869892-C1B49E6C-16DD-4378-96E0-AC22EE2150AEQ35895851-EF79F427-D8F9-456F-B2A9-5F444F71926DQ35909944-E97C0ACF-1256-49EB-AA66-56273E2014D7Q39878736-499460BF-E0AD-40BD-A33F-723DADEDA149
P2860
A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
A vaccine-elicited, single vir ...... unodeficiency virus challenge.
@ast
A vaccine-elicited, single vir ...... unodeficiency virus challenge.
@en
type
label
A vaccine-elicited, single vir ...... unodeficiency virus challenge.
@ast
A vaccine-elicited, single vir ...... unodeficiency virus challenge.
@en
prefLabel
A vaccine-elicited, single vir ...... unodeficiency virus challenge.
@ast
A vaccine-elicited, single vir ...... unodeficiency virus challenge.
@en
P2093
P2860
P1433
P1476
A vaccine-elicited, single vir ...... munodeficiency virus challenge
@en
P2093
C R Alving
J A Kessler
N M Wassef
Y Yasutomi
P2860
P304
P407
P577
1995-04-01T00:00:00Z